Albany Molecular Resh Inc (NASDAQ:AMRI)

CAPS Rating: 2 out of 5

The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.

Recs

1
Player Avatar exemployee1 (< 20) Submitted: 4/11/2010 7:48:29 AM : Underperform Start Price: $8.53 AMRI Score: -2.03

This company is not at all well run. It does not take care of its employees. Instead, it uses them and throws them away resulting in excessive turn over. Communication within the company is highly controlled and honesty will result in retaliation. This is all easily verifiable. Ask any of the literally hundreds of people who no long work for them. This is a signal of institional sickness and the buck falls at the very top...but money keeps some people in control.

Featured Broker Partners


Advertisement